Loading…
Reported covered position: Legis. Asst., Sen. Durbin; Fellow, Sen. Stabenow
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Issues related to Medicare and Medicaid reimbursements.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Source: Senate LDA
| FRESENIUS MEDICAL CARE |
| 3 |
| 2013–2014 |
| AETNA, INC. | 2 | 2013 |
| BOOZ ALLEN HAMILTON | 2 | 2014 |
| PFIZER, INC. | 2 | 2014 |
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Preventing Diabetes in Medicare Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Medicare Diabetes Prevention Act of 2013
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation.
Supporting the goals and ideals of the MAGIC Foundation.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
National Diabetes Clinical Care Commission Act
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
A resolution supporting the goals and ideals of "Growth Awareness Week".
Client: NOVO NORDISK INC. · Firm: DLA PIPER LLP (US)
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
National Diabetes Prevention Program.
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Issues related to Medicare/Medicaid reimbursements.
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; prescription drug abuse.
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Medicare Advantage risk adjustment.
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2014 · fourth_quarter · 4T
Health care financing.
BOOZ ALLEN HAMILTON via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Implementation of the Patient Protection and Affordable Care Act (Pub. L. No. 111-148).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOOZ ALLEN HAMILTON via DLA PIPER LLP (US)
2014 · third_quarter · RR
Implementation of the Patient Protection and Affordable Care Act (Pub. L. No. 111-148).
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Medicare Advantage risk adjustment.
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Health care financing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PFIZER, INC. via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions affecting the pharmaceutical industry; prescription drug abuse.
Issues related to Medicare/Medicaid reimbursements.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Issues related to the prevention and treatment of diabetes, including diabetes screening; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
National Diabetes Prevention Program.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242 and S. Res. 489, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Health care financing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Medicare Advantage risk adjustment.
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · second_quarter · Q2
Issues related to Medicare and Medicaid reimbursements.
Filing targets: SENATE
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
Filing targets: Executive Office of the President (EOP), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · first_quarter · 1A
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Issues related to Medicare and Medicaid reimbursements.
CENSEOHEALTH via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Medicare Advantage risk adjustment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2014 · first_quarter · Q1
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Issues related to Medicare Part D and Medicaid rebates; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; "Diabesity" amendment to S. 1871, SGR Repeal and Medicare Beneficiary Access.
Issues related to the prevention and treatment of diabetes; Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act; Special Diabetes Programs reauthorization; S. Res. 242, supporting the goals and ideals of "Growth Awareness Week"; H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2014 · first_quarter · Q1
Health care financing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR CONNECTED CARE via DLA PIPER LLP (US)
2014 · first_quarter · RR
Modernize federal policies regarding telehealth and remote patient monitoring.
Modernize federal policies regarding telehealth and remote patient monitoring.
CENSEOHEALTH via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Medicare Advantage risk adjustment.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
CENSEOHEALTH via DLA PIPER LLP (US)
2013 · fourth_quarter · RR
Medicare Advantage risk adjustment
AETNA, INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation; H.R. 1074 and S. 539, National Diabetes Clinical Care Commission Act.
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
BLUE CROSS AND BLUE SHIELD ASSOCIATION via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Implementation of Public Law No. 111-148; issues related to the Federal Employee Health Benefits Program.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · fourth_quarter · Q4
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Issues related to Medicare and Medicaid reimbursements.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
COALITION ON HEALTH CARE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Health care financing.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AETNA, INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Implementation of Public Law No. 111-148, provisions related to CMS Innovation Center programs; care coordination initiatives; health information technology; wellness initiatives.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FRESENIUS MEDICAL CARE via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Medicare and Medicaid reimbursement for end-stage renal disease patients.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NOVO NORDISK INC. via DLA PIPER LLP (US)
2013 · third_quarter · Q3
Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25, Budget Control Act of 2011 and H.R. 8, American Taxpayer Relief Act of 2012; H.R. 1588/S. 740, Medicare Drug Savings Act of 2013; H.R.962/S. 452, Medicare Diabetes Prevention Act of 2013; H.R. 1257, Preventing Diabetes in Medicare Act of 2013.
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Issues related to the prevention and treatment of diabetes. Implementation of Public Law No. 111-148, the Patient Protection and Affordable Care Act. Special Diabetes Programs reauthorization. S. Res. 242, supporting the goals and ideals of "Growth Awareness Week." H. Res. 313, supporting the goals and ideals of the MAGIC Foundation.
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE